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Abstract 
In nature, cells respond to complex mechanical and biological stimuli whose understanding is 
required for tissue construction in regenerative medicine. However, the full replication of such 
bimodal effector networks is far to be reached. Engineering substrate roughness and 
architecture allows regulating cell adhesion, positioning, proliferation, differentiation and 
survival, and the external supply of soluble protein factors (mainly growth factors and 
hormones) has been long applied to promote growth and differentiation. Further, bio-inspired 
scaffolds are progressively engineered as reservoirs for the in situ sustained release of soluble 
protein factors from functional topographies. We review here how research progresses 
towards the design of integrative, holistic scaffold platforms based on the exploration of 
individual mechanical and biological effectors and their further combination.  
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Introduction  
A deep understanding of cell adhesion, positioning, migration, proliferation, apoptosis and 
differentiation and the precise control of the underlying mechanisms are necessary for the 
generation of fully functional artificial tissues. The comprehension of how cells organize into 
complex structures requires the identification of the different participating effectors and how 
they combine for specific, time-dependent cell responses. This is especially critical for the 
reconstruction of damaged tissues that involves the controlled cultivation of stem cells on 
artificial scaffolds, either straightforward in vivo, or ex vivo followed by implantation into 
damaged organs. In both cases, manmade scaffolds are expected to be biocompatible, 
mechanically stable and when required fully biodegradable (depending on how the 
regenerative process has been designed). They must also provide a bio-inspired topography 
within cell dimensions range to support cell colonization, mimicking to that offered in vivo by 
the extracellular matrix (ECM). This is because mechanic stimuli have been revealed as critical 
for cell proliferation, positioning and differentiation, acting through cell sensing and 
mechanotransduction events (1). Then, the de novo designed scaffolds for tissue engineering 
must address precise topographical requests at micro and nano scales apart from exhibiting 
defined material properties affecting cell behavior such as two-dimensional/three-dimensional 
(2D/3D) geometry, appropriate stiffness and surface charge.  
In the ECM, mechanical stimulation is combined with the activity of biological effectors mainly 
based on soluble molecules such as hormones, growth factors (GF), signal transducers and 
probably a set of still unidentified agents released by neighboring cells. Also, the ECM itself, 
based on diverse types of protein materials, displays cell adhesive and topographical 
properties that regulate cell fate (2). The combined action of biological and mechanical agents 
generates a complex stimuli pattern that supports the dynamics of tissue formation and 
vascularization (3). Then, any potential of a synthetic scaffold to act, in addition to topographic 
modulator, as a reservoir of bioactive compounds for their sustained release is highly 
appealing, especially for in vivo applications in which external drug supply might be restricted. 
In this regard, mechanical stimulation in combination with the supply of these factors 
represents the best approach to mimic the natural cell environment in artificial sets. However, 
the enormous complexity of the natural effector network and the synergistic activities of their 
components delay the desirable combined application of modulators in tissue engineering. 
Then, both type of effectors are often developed and tested separately, and only a moderate 
number of strategies are addressing the integrative supply of mechanical and biological 
signals. Importantly, proteins represent particularly intriguing materials as they can provide, 
simultaneously, architecture and functionality to cell substrates. The main trends in the 
topographical design of scaffold materials as well as the biological nature of protein-based 
effectors of relevance in tissue engineering are revised here. We particularly stress emerging 
developmental routes towards biofunctional scaffolds empowered to present both mechanical 
and biological stimuli in a cell sensing range. 
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Engineering scaffold topography 
Plain topographical stimuli. Synthetic topographies affect basic functions in almost all types of 
mammalian cells. Therefore, engineering substrates within the size range at which ECM 
mechanical effectors trigger cell responses (4) offers a powerful tool to study and regulate 
complex cell functions such as adhesion, migration, cytoskeleton reorganization and cell 
polarization (5,1) that might be useful and exploitable for specific tissue engineering purposes. 
Although responses vary across cell type and substrate properties, some general lessons can 
be extracted from the rapidly growing body of literature (Table 1). These data could then be 
exploited to iteratively probe, engineer and improve cell–nanotopography interactions for 
tissue engineering applications though the manipulation of the mechanical stimuli to which 
cells are exposed (6). 
Mechanical stimulation has been explored through the lithographical modification of polymers 
or other surfaces (top-down approach) to generate micro- and nano-grooves or pits (bottom-
up approach) (7,8). The use of such modified substrates permits, in addition, the regulation of 
the expression of cell adhesion molecules (9), the distribution of focal adhesions (10) and the 
orientation of whole cells as well as their morphological appearance (11). Microcontact printing 
(µCP)(12) is recognized as a cost-effective, fast and versatile technique to control surface 
chemistry at the microscale over considerably large areas (up to hundreds of mm2). The range 
of materials that can be used to cover surfaces using this method is broad (13): self-assembled 
monolayers (SAM´s) (14), proteins (15) and nucleic acids (12) among others giving rise to functional 
surfaces (16) which are obtained by multistep protocols. Although in most cases the “ink” used 
in this printing procedure consists of a solution of the molecules of interest, such soft-
lithographic method can also be extended to pattern colloidal particles (17) or even bacterial 
cells (18), expanding the functionalities of the engineered surface. 
Alternatively, several categories of particulate materials have been explored for the 
nanomorphological modification of scaffold surfaces (bottom-up approach), including 
ceramics, polymers and nanotubes (19,20,21,22). Particle-based surface decoration is highly 
promising since it is less dependent on the chemical nature of the scaffold material in contrast 
to lithographical modification. It allows, in some materials, important levels of topographical 
flexibility and controllable effects on cells, as exemplified by the use of nanotubes as substrate 
modifiers. In this context, the viability and activity of MSCs cultured on TiO2 nanotubes can be 
controlled by the tube diameter (23). Vertically aligned TiO2 nanotubes with a diameter larger 
than 50 nm dramatically reduced cell activity and caused programmed cell apoptosis. 
Compared to smooth TiO2 surfaces, a lateral spacing of 15–30 nm strongly promoted focal 
contact formation and enhanced cell activities (24). Using this platform, the influence of 
integrated nanoscaled topography and GFs to stem-cell fate has also been investigated, 
facilitating the further developments of medical implants and materials. 
Combined topographical stimuli. In this context, recent approaches focus on two or more 
combined engineering strategies to achieve complex combined stimuli. Hot embossing has 
been applied to control topography and µCP for a chemical patterning, to obtain substrates 
with grooves covered with perpendicular stripes of proteins (25), while a similar architecture 
has been also generated but with parallel patterns (26). Recknor and coauthors co-cultured 
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astrocytes with adult rat hippocampal progenitor cells over chemically modified 
micropatterned polystyrene substrates and they preferentially acquire neuronal morphology 
depending on the microstructuration of the substrate (27). These examples indicated that 
substrate topography in synergy with chemical modification and biological guidance facilitates 
cell differentiation. Also in this regard, we have recently shown that bacterial inclusion bodies 
(IBs), pseudospherical protein clusters spontaneously formed in recombinant bacteria, can be 
used as biocompatible materials for surface decoration and stimulation of mammalian cell 
spread. Since IB formation is multigenetically determined through the cell quality control 
system, mechanical, morphological, structural and biological properties of IBs can be adjusted 
by the genetic manipulation of the producing cells. IBs show a positive impact on colonization 
and proliferation (28,29), and being highly bioadhesive materials, cell expansion on IB-decorated 
surfaces has been proven to be synergistically supported by both favored adhesion and 
mechanical stimulation of cell division (30). In micropatterned surfaces, cells preferentially 
adhere to IB-rich areas, aligning and elongating according to the IB pattern and choosing the 
shortest way to reach new adhesion spots on the IBs (31). Such 2D engineering technique fills 
the gap between existing techniques which are based on the local modification of the chemical 
nature of the surface and those based on the modification of the topography at the nanoscale 
level by physical methods because IBs combine at the same time biofunctionalization and 
topographical modification of the roughness, as discussed in more detail above. 
3D topographies. 3D scaffolds are expected to mimic the ECM and the natural cell 
environment more accurately than conventional 2D surfaces. Apart from metals, ceramics, 
protein-based hydrogels and carbon nanotubes, a spectrum of biocompatible and 
biodegradable polymers is being explored for ex vivo 3D culture and subsequent 
implantation, including hyaluronic acid (HA), polylactic acid (PLA), polyglycolic acid (PLGA), 
chitosan (CHT), hydroxyapatite,  polycaprolactone (PCL), polyanhydrides, polyorthoesters and 
dendrimers (32,33,34). Controlling the material architecture during biofabrication permits the 
pre-definition of porosity for mass transfer and proper colonization of the inner surfaces. 
In addition, 3D scaffolds are expected to offer disordered mechanical stimuli for mechano-
transduction events (35,36), required for a fine control of cell response, more efficiently than 2D 
substrates. Since ideally, mechanical stimulation should act synergistically with biological 
signals, 3D scaffolds might be appropriate as combined with sets of soluble factors embedded 
in the matrices, as discussed in deep below. This is exemplified by the emerging biomimetic 
materials used in implants for bone regeneration such as nano-hydroxyapatite/polyamide66 
and derivatives (37) that show excellent biocompatibility, stability and osteoconductivity. 
When used in the fabrication of screws can be loaded with GFs to confer additional biological 
activities to the material and successfully fix intercondylar femur fractures (38). In addition, 
related hydroxyapatite materials can be loaded with antibiotics for sustained release in vivo 
to prevent bacterial infections subsequent to surgery (39). 
 
 
 
6 
 
 
Table 1. Topographical control of cell proliferation, morphology and positioning, illustrated by 
representative examples. 
 
 
 
 Feature geometry Impact on cell Reference 
 
Substrate 
material 
 
Feature type 
 
Cell type 
Width Depth 
  
Quartz Grooves  Murine 
P388D1 
macrophage 
0.5, 5, 10, 
25 μm 
0.5, 
5 μm 
Orientation 
change and 
Elongation, more 
in wider grooves 
(40)
 
Quartz Grooves Mesenchymal 
stem cells 
1. 4  μm 1.1  μm Alignment better 
in the widest 
grooves 
(41)
 
Quartz Grooves Fibroblasts 12.5 μm 5 μm Gene expression 
largely changed 
(42) 
Quartz Grooves Murine 
macrophages 
2-10 μm 30-280 
nm 
Higher 
phagocytotic 
activity when 
topography fiber 
(43) 
Quartz Grooves Human 
corneal ECs 
1-4 μm N/D Elongation 
(44)
 
 
Silicon Grooves Humancornea
l epithelial 
cells 
330-
2100 nm 
600 nm 
Perpendicular 
alignment for 
400–800 nm 
pitch. Parallel for 
1600–4000 nm 
(45)
 
Silicon dioxide Grooves Fibroblasts 0.5  μm 1 μm Strong alignment 
(46)
 
Silicon dioxide Grooves Keratinocytes 0.5  μm 1 μm No alignment 
(46)
 
PMMA Grooves BHK cells 2, 3, 6, 12 
 μm 
0.2, 0.5, 
1.1,1.9 
μm 
Alignment 
increased with 
depth and 
decreased with 
width 
(47)
 
PMMA Steps BHK  1-18 μm N/D Alignment at 
steps 
(47)
 
PMMA Pillars Fibroblasts 100 nm 160 nm Smaller, less 
organized actin 
cytoskeleton 
(48)
 
PCL,PMMA Pits Fibroblasts 35, 
75,120 n
m 
N/D Reduced 
adhesion, 
orientation and 
distinction of 
symmetries 
(49,50,51)
 
PCL, PMMA Nanopit Human 
fibroblasts 
35-120 
nm 
N/D Adhesion 
decreased and 
biased orientation 
(52)
 
 
PCL Nanopit Human 
fibroblasts 
35-120 
nm 
N/D Spreading 
decresed. 
Increased 
filopodia 
(53) 
PCL Nanopit and 
nanopost 
Rat 
fibroblasts 
60-150 
nm 
N/D Adhesion 
decreased and 
increased 
adhesion on 
random 
(54)
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nanoposts 
PS Grooves Rat 
astrocytes 
10 μm 3 μm Less adhesion, 
strong alignment 
(55)
 
PS Grooves Fibroblasts 20-
1000 nm 
5-
530 nm 
No alignment for 
depths <35 nm or 
widths <100 nm 
(56)
 
PS Grooves Rat bone cells 1-10 μm 0.5-1.5 
 μm 
Width > 5 μm: 
cells followed the 
surface. Narrow 
grooves: cells 
bridge 
(57)
  
PS Grooves Rat bone 
marrow cells, 
osteoblasts 
MC3TC 
Micro 
(manual) 
N/D RBMC influenced 
by grooves 
(osteoblast 
differentiation) 
MC3T4 not 
influenced 
(58)
 
 
PS Grooves rC6 glioma 266 nm N/D Elongation 
(59) 
PS Grooves hEKCs (HEK-
293) 
200-430 
nm 
N/D Elongation. 
Increased 
proliferation 
(60) 
PS Grooves Human 
corneal ECs 
2-20 μm N/D  Elongation, lower 
cell area. 
(61)
 
 
PS Grooves Rat bone cells 1-10  μm 0.5-
1.5 μm 
Large grooves: 
focal adhesions all 
over the surface; 
Narrow grooves: 
only on the edges 
(57)
 
PS Nanopost HeLA 160-1000 
nm 
N/D Spreading 
decreased. No 
effect on 
proliferation 
(62)
 
 
PS and PBrS Random Human 
endothelial 
13, 35, 9 5 
nm 
N/D Round cells on PS, 
Arcuate 
morphology 
largest for the 13 
nm islands 
(63) 
Polyimide Grooves Osteoblasts 4  μm 5 μm Strong alignment 
and elongation no 
changes in 
adhesion 
(64)
 
PDLA Grooves Schwann cells 
(nerve cells) 
10  μm 3 μm Strong alignment 
(65)
 
PLGA, PU, PCL Random Bladdersmoot
h 
Muscle cells 
206, 
370 nm 
N/D Enhanced 
adhesion 
 
(66)
  
Epoxy Grooves Human 
fibroblasts 
0.5 μm 1 μm Cytoskeleton 
oriented with 
grooves 
(67)
  
PLLA, PS Grooves Rat bone cells 1,2,5,10 μ
m 
0.5,1,1.
5 μm 
Better 
mineralization 
with feature 
diameter of 1 μm 
and feature width 
of 1–2 μm 
(68) 
PDMS Grooves Human 
embryonic 
stem cells 
600 nm 600 nm Reduced 
proliferation 
(69) 
PDMS Wells Human 
fibroblasts 
2,5,10 μm N/D With 2 and 5 μm 
better 
proliferation. 10 
mm has no effect 
(70)
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PDMS Grooves Human 
endothelial 
cells 
600 nm N/D Decreased 
proliferation. 
Elongation, lower 
cell area 
(71) 
PDMS Grooves Human 
embryonic 
stem cells 
600 nm N/D Elongation. 
Adhesion 
decreased and 
decreased 
proliferation, 
cytoskeleton 
disrupting agents 
impact response 
(69)
 
 
PDMS Grooves Human 
mesenchymal 
stem cells  
350 nm-
10 μm 
N/D Elongation, lower 
cell area. 
Decreased 
proliferation, 
differentiation 
into neuronal 
lineage 
(72)
 
 
PMMA Wells, random Human 
mesenchymal 
stem cells 
120 nm 100 nm Stimulated 
differentiation 
and production of 
bone mineral in 
vitro 
(36)
  
 
PMMA Random Bone marrow 
cells (stem 
cells) 
100-
2000 nm 
N/D Differentiation to 
osteoblasts 
promoted, cells 
organize into 
superstructures 
(73) 
PMMA Nanopit Human 
mesenchymal 
stem cells 
300 nm N/D Osteogenic 
differentiation 
(36)
   
 
PMMA Pillars Fibroblasts 100 nm 160 nm Less spreading 
(74) 
PDMS, PMMA Grooves Bovine 
smooth 
muscle cells 
350 nm N/D Elongation. 
Decreased 
proliferation, 
polarized 
microtubule 
organization 
center 
(75)
 
 
PLGA Random Rat aortic 
smooth 
muscle cells, 
rat aortic 
endothelial 
cells 
Nano-
range 
N/D Improve on cell 
densities with the 
nanostructure 
(76) 
PEG Nanopost Rat 
cardiomyocyt
es 
150 nm N/D Adhesion 
increased 
(77)
 
 
PEG Nanopost mP19EC stem 
cells 
300-500 
nm 
N/D Adhesion 
increased 
(78)
 
 
PC Nanopit Human bone 
marrow cells 
300 nm N/D Spreading 
decresed. 
Constant filopodia 
formation N/D 
(79)
 
 
PC Nanopit Human 
osteoblasts 
300 nm N/D Adhesion 
decreased. 
Reduced area of 
adhesion 
complexes 
(80)
 
 
PGS Grooves Bovine 
endothelial 
2 μm N/D Elongation 
(81) 
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cells 
Si Nanopost Fibroblasts 50-600 
nm 
N/D Spreading 
decresed. No 
effect on 
proliferation 
(82)
 
 
Si Grooves PC12 70-1900 
nm 
N/D Elongation.  
Cooperative 
neurite extension 
(83)
 
 
Si Nanopit Human 
fibroblasts 
80 nm N/D Spreading 
decresed 
(79) 
Si Grooves Human 
corneal ECs 
70-2100 
nm 
N/D Elongation, lower 
cell area.  
Adhesion 
increased. Biased 
lamellipodioa 
extension 
(45,84)
 
 
Si Grooves Human 
fibroblasts 
50-600 
nm 
N/D Elongation, lower 
cell area. 
Decreased 
proliferation 
(82)
 
 
Ti Grooves Fibroblasts 3-5 nm N/D Elongation. No 
effect, increase in 
fibronectin mRNA 
incorporation 
 
(85)
  
 
Ti Grooves Rat 
endothelial 
cells 
750 nm-
10 μm 
N/D Increased 
adhesion and 
longation 
(86)
 
 
Ti-coated Si Grooves T24, human 
bladder 
carcinoma 
15 μm 200  nm Nanopillars: less 
round and more 
stellate, smaller 
Grooves: 
elongatio 
(87)
 
Alumina Pillars, pores Mouse 
marrow 
stromal cells 
110, 72 
nm 
N/D Proliferation 
increased 45% 
increased 
osteoblast 
differentiation 
(88)
 
 
Silica on PEI-
coated silicon 
gradient 
concentration 
Beads Rat calvarial 
osteoblasts 
73 nm 73 nm Particles 
(nanotopography) 
reduced cell 
proliferation 
(89) 
 
Abbreviationlist:N/D:non-determined;PMMA:poly(methylmethacrylate);PDMS: poly-dimethyl siloxane; PC: 
polycarbonate; PS: polystyrene; PLLA: poly(L-lactideacid); PET: poly(ethyleneterephthalate); PBrS: poly(4-
bromostyrene); PCL: polycaprolactone; PDLA: poly(D,L-lactic acid); PLGA: polylactic-co-glycolic-acid; PU: polyether-
urethane.  
 
Tailoring bio-functional protein materials 
Promoting cell adhesion through protein coating. Often, fabrication constraints, 
biocompatibility, durability and the need to control precise architectural, topographical or 
chemical profiles impose the use of unfriendly materials as prototype scaffolds for tissue 
engineering. Coating these scaffolds with ECM proteins such as fibronectin (FN), the most 
adhesive glycoprotein, collagen I or III, laminin-I, elastin and vitronectin facilitates cell adhesion 
and colonization (Table 2). These proteins adsorb to almost any surface, including metals, 
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organic biopolymers and ceramics (90), by binding forces responsible for the “Vroman effect” 
(91). Due to their difficult extraction from natural sources, many ECM proteins have been 
produced in recombinant forms. Since during adsorption full-length proteins may suffer 
conformational changes that hide functional domains critical for cell interaction (92), coating 
with functional ECM protein fragments, like the 120-KDa FN segment or peptide epitopes like 
RGD (Arg-Gly-Asp), found in many adhesive ECM glycoproteins, might be highly convenient. 
RGD motives need to maintain its native stereo conformation (cyclic form) to exhibit full 
binding activity (240 times more active than the linear peptide) (93), what poses important 
challenges in peptide design and synthesis. Other integrin-binding peptides from ECM are 
REVD, KQAGDV and PHSRN derived from FN; YIGSR, IKLLI, LRE, LRGDN, PDGSR, LGTIPG and 
IKVAV derived from laminin or GFOGER p15 and DGEA derived from collagen. Scaffold coating 
with adhesive ECM epitopes gives the opportunity to control not only peptide density but also 
clustering through nanopatterning, which in turns regulates cytoskeletal organization, focal 
contact, proliferation, adhesion and differentiation (94), as discussed above. 
Also, scaffolds themselves can be made of collagen, elastin or polysaccharide nanofibers like 
hialuronic acid (HA), cellulose, alginate, chitin and chitosan. Scaffolds of native collagen type I 
have been extensively used in cell biology and 3D collagen gels have been successfully applied 
to skin regeneration and cartilage repair, as they promote convenient cellular behavior in 
terms of migration, shape and differentiation. Scaffolds of native and recombinant elastin have 
been used in vivo for tissue engineering of skin and vascular tissues with promising results. On 
the other hand, HA scaffolds are widely employed in ophthalmology, as joint lubricants and in 
tissue engineering of cartilage and skin, due to the pleiotropic cellular effects derived from HA-
CD44 interaction (for a review, see (95)). Finally, keratin biomaterials derived from human hair 
are suitable to induce cell adhesion, proliferation and migration (96). 
In a related scenario, elastin-like polypeptides (ELPs) are recombinant alternatives derived 
from elastin, which maintain biocompatibility for in vivo applications and show structural 
responsiveness to temperature. ELPs are formed by repeats of the elastin primary sequence 
VPGXG. They are used to construct scaffolds for the regeneration of different tissues (dermal, 
vascular, cardiac, cartilage), but also to coat different materials too hydrophobic or negatively 
charged to allow cell adhesion and growth (97). 
Unconventional and emerging adhesive proteins. Silk fibroin (SF), a silk protein produced by 
silkworms, exhibits excellent biocompatibility, good oxygen and water vapor permeability, 
biodegradability, triggering a minimal inflammatory reaction (98) . In practice, SF has been used 
in cosmetics, as a medical material in human medicine and as food additive. Electrospun SF 
matrices have been developed as a support for culture of fibroblasts and keratinocytes (99), 
bone marrow stem cells (BMSC) (100), human aortic endothelial cells (HAEC) and human 
coronary artery smooth muscle cells (HCASMC) (101), resulting in positive effects on cell 
adhesion, viability, growth, and differentiation. On the other hand, mussel adhesive proteins, 
with outstanding adhesive properties even in aqueous environment, have been used as 
scaffolds for bone regeneration (102) and have inspired the generation of polydopamine in 
different formats, useful in re-endothelialization of artificial vessels (103). They are commercially 
available as Cell-Tak (BD Bioscience, Corning), which is an extracted mixture of fp-1 and fp-2, 
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useful to immobilize in vitro different cells and tissues on glass, plastic or even metals (Table 
2). 
Also, many non-natural peptides relevant to cell adhesion, proliferation and spreading have 
been obtained by genetic modification of natural sequences, by screening combinatorial 
peptide libraries and by combining bioinformatics and protein structural data to adjust and 
optimize adhesive properties for specific cell types. These strategies and the resulting peptides 
have been extensively revised and summarized elsewhere (104). 
Cell adhesion in bone tissue engineering. Many studies addressed to elucidate the molecular 
basis of osteogenesis from MSCs have demonstrated that substrate protein coating might be 
decisive in different phases of bone generation, mimicking the activities of corresponding 
soluble protein versions. FN to promote initial MSC adhesion and proliferation, bone 
morphogenetic protein 2 (BMP-2) as active agent in a second stage of differentiation and bone 
matrix production, osteopontin (OPN) and bone sialoprotein (BSP) to promote cell adhesion 
and differentiation into osteoblasts and osteoclasts, and tenascin (TN) to induce mineralization 
and new bone formation. Interestingly, FN effects differ depending on the type of coated 
material, probably due to conformational changes induced upon adsorption. In fact, the 
adhesion properties of OPN and BSP are enhanced when coated in their oligomerized forms 
(105). 
 
Developing functional drug-releasing biomaterials 
Hydrogel architecture. As mentioned above, the recreation of micro- and nano- topographies 
and cell-friendly surfaces for efficient attachment should be combined with biochemical 
signaling, desirably achieved by the release of soluble factors such as GFs, cytokines and other 
bioactive molecules (Figure 1). Among the broad range of available materials, the 
supramolecular organization of fibrous structures made of polysaccharides, proteins or short 
peptides can be easily modulated in terms of physicochemical features and can potentially act 
as reservoirs of soluble factors for their fine controlled release. In this context, hydrogels are 
injectable polymer-based biomaterials able to generate 3D networks with a huge potential in 
biomedicine. Interestingly, there is a broad catalogue of hydrogels, since they can be formed 
by different natural or synthetic polymers. Their generic architecture, swelling properties, pore 
size, interconnectivity, morphology and mechanical properties can be modulated through the 
fabrication of homopolymers, copolymers, by interpenetrating, double networking or by 
choosing covalent or physical interactions for the network construction (106). Although 
hydrogels show by themselves interesting properties as scaffolds for tissue engineering, many 
efforts have been devoted to the development of artificial extracellular matrices based on 
hydrogels that offer not only mechanical but also biological cell-instructive cues, such as the 
targeted presentation of GF (107,108). 
Hydrogel-based GF release. GFs have critical roles in cell proliferation, differentiation and 
survival, being the main source of biomolecular cues in any tissue engineering approach. 
Specifically, BMPs, transforming GF (TGFs), vascular endothelial GF (VEGF), fibroblast GF 
(FGFs), nerve GF (NGF) and insulin-like GF (IGFs) are the most important soluble effectors 
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involved in the tissue regeneration processes (109) (Table 2). The administration of such GFs has 
already been tested through the injection of their soluble versions. However, first clinical trials 
have shown low efficiency due to uncontrolled delivery. In this regard, hydrogels have 
appeared as a promising scaffold for GF immobilization and sustained release (107). On the one 
hand, through the immobilization of GFs in hydrogels, the stability as well as the specific 
spatio-temporal delivery of such key signaling molecules can be defined and improved. 
Moreover, further developments of such delivery platforms are expected to reduce the doses 
of GF to reach the desired effect. On the other hand, the embedment of such GF in hydrogel 
matrices allows the generation of biomaterials able to mimic both the biological and physico-
chemical functions of the extracellular milieu. 
GFs (or any other drug of interest) can be immobilized in scaffolds and matrices by simple 
dispersion or physical entrapment, but also via biochemical or covalent links between the 
molecule of interest and the scaffold (110). Since during the immobilization process, bioactivity 
of the protein or other drugs might be affected, a pre-treatment with poly-ethylenglycol (PEG) 
and an optimal buffer for drug encapsulation in micro- or –nanoparticles can notably improve 
the resulting bioavailability and bioactivity. Once immobilized, GFs are released from the 
scaffold by simple diffusion or via degradation of the polymeric matrix (109). Promising 
prototypes of biomimetic hydrogels designed for GF delivery have been generated for skeletal 
regeneration, angiogenesis and vessel formation, and nerve regeneration, among others. 
Regarding bone tissue repair, different authors have proven the potential of different types of 
structures namely gelatine-poly(propylene)-based hydrogels (111), hybrid hydrogels (107), fibrin-
based hydrogels (110) and alginate-based hydrogels (112,113,114), among others, combined with 
GFs. Interestingly, many of these studies have used GF-loaded microspheres to increase 
protein stability (111,107), observing promising results in vitro. 
Hydrogels for bone and cartilage regeneration. The combined delivery of TGF-3 and BMP-2 
incorporated in alginate hydrogels is highly efficient and more effective for bone regeneration 
than free versions (112). In agreement, the potential of GF release from hydrogels to regenerate 
bone tissue has been also demonstrated in rat, rabbit, sheep and dog (110). As a complementary 
approach, the addition of integrin binding sites adjacent to GF-binding sites improves the final 
result (19). Very recently, the generation of a novel and improved type of GF-releasing hydrogel 
has been described, able to stimulate ex vivo bone development and tissue repair (113,114). 
Specifically, the authors have used a novel decellularized, demineralized bovine bone 
extracellular matrix combined with an alginate hydrogel as scaffold. Besides, this biomaterial 
was decorated with microparticles containing GFs and capable of releasing such GFs in a 
temporal and controlled manner. Individually, VEGF enhances cell migration, TGF-3 
stimulates cell proliferation, and BMP-2 specifically enhances collagen deposition. However, 
dual combinations of these GFs show a synergic effect, being possible to simultaneously induce 
migration and collagen deposition when using VEGF and BMP-2, and observing a greatest 
influence on tissue deposition when combining TGF-3 and BMP-2 (113,114). Furthermore, 
engineered hydrogels can be used to stimulate cartilage regeneration (115). Considering that 
MSCs are a promising source for cartilage regeneration and that TGF- family has a key role in 
the chondrogenesis process of MSCs, Jung and collaborators have designed Cyclodextrin(CD)- 
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and Cucurbituril(CB)-based hydrogels able to deliver TGF- through a spatiotemporal control in 
vivo, showing again promising results (115). 
Hydrogels for angiogenesis. Since angiogenesis is clearly dependent on the activity of GFs such 
as VEGF, FGFs and angiopoietin-1, hydrogels have a high potential as GF releasing systems also 
in this field. PEG-based hydrogels, combined with covalently-linked VEGF, have shown the 
ability not only to stimulate cell migration and proliferation, but also to maintain their viability 
(116,117). Interestingly, it has been observed, as it has previously mentioned for skeletal tissue 
regeneration, an improved effect of RGD motifs when administered simultaneously to two GFs 
in both a chicken chorioallantoic membrane (CAM) assay and in an in vivo model (117). In line 
with these studies, Thomas and co-workers have developed an advanced type of PEG 
hydrogels for localized and sustained delivery of angiogenic factors, using immobilized 
lentiviruses as GF expression system. Specifically, virus particles were incorporated in heparin-
chitosan nanoparticles, which were finally immobilized onto a PEG porous structure. 
Interestingly, an increase of endothelial cells and blood vessels around the hydrogel used was 
observed using both in vitro and in vivo approaches (118). 
Hydrogels for nerve tissue regeneration. Although the peripheral nervous system has a 
regenerative potential after nerve injury this not ensures complete tissue regeneration and in 
this context, hydrogels have also been used as controlled GF delivery platforms. For instance, a 
PLA-b-PEG-b-PLA microgel loaded with NGF  and gelatin-based hydrogels loaded with VEGF (119) 
have been extremely efficient. Microgels, which can be directly injected into the tissue, have 
shown the ability to release NGF through 22 days in vitro (120). On the other hand, Gnavi and 
collaborators have evaluated VEGF release from gelatin-based hydrogels using Schwann cells 
and Dorsal root ganglia (DRG) explants (models for glia and motor neurons), concluding that 
this biomaterial induces neurite outgrowth from DRG explants (119). 
Amyloid engineering. Many protein and peptides have the natural capability to generate 
supramolecular fibrillar structures rich in beta-sheet conformation and stabilized by 
noncovalent interactions. This fact can be explained by the inherent physicochemical features 
of the protein and peptide backbone which exhibits a high propensity to establish hydrogen 
bonds, allowing the growth and stability of the protein/peptide amyloid fibers (121). These 
amyloids, although firstly regarded as hazardous elements in several pathologies such as 
Alzheimer, Parkinson or Huntington disease are increasingly showing promise in the field of 
biomaterials as self-assembly protein fibrillar scaffolds. The capacity of generating a fibrillar 
matrix, resembling in composition and conformation the natural ECM, has focused the interest 
for this type of material in regenerative medicine, tissue engineering and other medical 
applications (122). Additionally, the discovery of functional amyloids by Maji and co-workers, as 
reservoir of more than 30 releasable human hormones, opens the possibility of reaching a 
tight spatial and functional control of protein release from amyloid materials (123). In this 
regard, amino acid stretches forming the amyloid building blocks can be chemically modified 
to finely regulate the disassembly of the fibrillar matrix. In particular, light-triggered release of 
the amyloid fibril building blocks can be an appealing and versatile approach. Measey et. al 
have provided evidence of how a simple substitution of lysines by a photocaged variant 
lys(Nvoc) allows the generation of amyloid fibrils with the capacity of disassembly upon 
irradiation with UV light. The lysNvoc light-mediated cleavage release the moiety attached to 
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the side chain, restoring the regular amino acid properties and providing a significant change in 
the hydrophobicity that causes the disassembly of the amyloid fibril (124).  
 
Protein release from amyloid scaffolds. The plasticity shown by functional amyloids could be 
combined with other intrinsic features such as the slow release of the forming protein fibril. 
Elegant studies have tested the potential application of this platform for a sustained delivery of 
therapeutic proteins and peptides. This property would allow a significant improvement in 
treatments that require recurrent administration of the active molecule such as chronic or 
long-term diseases. In this context, amyloids formed by insulin or gonadotropin-releasing 
hormone (GnRH) analogues have been successfully designed. Thus, supramolecular insulin 
assemblies (SIA) have been proposed as a long-term solution to current administration of the 
soluble version. Luo and co-workers combined the SIA in Layer by Layer (LbL) films in order to 
obtain an insulin reservoir with very tight control of the molecule release. Subcutaneous 
implants of SIA structured in LbL films were applied to diabetic rats allowing the control of the 
glucose levels in an accurate manner during 295 days (125). Similarly, analogues of the GnRH can 
be used for the control of numerous sex steroid dependent pathophysiologies. These peptides 
are able to self-assemble in amyloid supramolecular structures with distinct stabilities and 
releasing properties depending on the analogue forming the amyloid fibril. Besides, 
subcutaneous implantation of GnRH analogs allowed the increase in the duration of the 
treatment compared to their soluble counterpart (126).  
Finally, bacterial IBs are functional amyloids that apart from the topographical potential for 
mechanical stimulation, cell adhesion and guidance discussed above, show high penetrability 
in mammalian cells and release the forming protein, in a functional form, inside cultured cells. 
These particles can be employed to add functionalities to 2D and 3D cell culture materials and 
exhibit a high versatility regarding the forming protein, its biological activity, and the 
physicochemical properties of the whole particle (127,128). Such functionalized surfaces support 
the intracellular delivery of biologically active proteins to up to more than 80 % of the 
colonizing cells, in a process slightly influenced by the chemical nature of the scaffold. The 
interesting combination of 3D soft scaffolds such as PLA and protein-based sustained release 
systems such as bacterial IBs (Bioscaffolds) (Table 2), offers promise in the fabrication of fully 
bio-inspired hybrid matrices for multifactorial control of cell proliferation in tissue engineering 
under complex architectonic setting-ups (129,130,131,132). Although the uses in vivo of IBs and other 
amyloid materials could be restricted by their potential toxicity and immunogenicity, the 
growing amounts of promising data obtained in cell culture and the emerging concepts around 
functional and non-toxic functional amyloids (133) prompt to envisage wide usability in ex vivo 
applications. Also, the absence of organic toxicity in oral administration of high IB doses (134), 
the possibility to obtain these materials in LPS-free cell factories (135) and the planned use of 
these particles to deliver homologous proteins such as GFs (then being formed by such 
homologous proteins) should ensure biocompatibility and minimize potential immune 
reactions in in situ tissue regeneration. 
Drug release from functionalized amyloids. Apart from the direct release of the amyloid 
building blocks, these matrices can be also functionalized by soluble effectors, expanding the 
possibilities of action by providing multiple stimuli to the target cells (Figure 1). In this regard, 
simple co-incubation of the soluble effector during the supramolecular structure formation can 
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be enough in order to entrap the soluble factor that would be progressively released during 
the degradation of the matrix. Following this principle, Chun et al incorporated retinoic acid to 
a K-casein amyloid hydrogel in order to gain control over neuronal differentiation (136). Other 
approaches consist in modifying the backbone of the amyloid building block to incorporate a 
tag with a high affinity for a complementary motif, fused to the soluble factor. Specifically, the 
biotin-streptavidin pair has been successfully explored in order to functionalize amyloid fibrils 
without altering their fibrillar structure. Incorporating biotin to the peptide forming the 
amyloid fibril as well as to the IGF-1 and linking both through a multivalent streptavidin, Davis 
and co-workers obtained amyloids capable to improve cardiac myocyte survival and growth. 
Thus, culturing ex vivo these cardiac myocytes on IGF-1 functionalized amyloids improved their 
further response upon implantation of the biomaterial in rat models of myocardial infarction 
(137). 
Peptide amphiphiles. Additionally to protein and peptide organization in amyloid structures, 
other molecules with peptidic nature confer extra levels of complexity to fibrillar architectures. 
In this regard, peptide amphiphiles (PA), generally composed by a peptidic hydrophilic head 
and an alkyl hydrophobic tail, allow the formation of micelles, fibers or even hollow tubes 
depending on the concrete nature of the PA used. Thus, we can find PA including cyclic 
peptides (138), bolaamphiphiles (139), surfactant-like peptides (140) or aromatic dipeptides (141). In 
general terms, the hydrophilic head is exposed to the solvent while the hydrophobic tails are 
disposed avoiding the contact with the solvent. As it happens with amyloid fibrils, PA self-
assembly and stability are also due to non-covalent interactions. PA fibers allow a higher 
plasticity in the fiber supramolecular organization although their building blocks cannot act as 
the own soluble effectors and should be functionalized. PA self-assembled fibers have also 
proved their applicability as biomaterials. In this sense, PA fibers functionalized with IKVAV or 
RGD peptides are able to influence neuronal cell alignment and migration. Neuronal cell 
alignment onto these matrices rendered enhanced neurite growth in both in vitro and in vivo 
assays (142). PA fibers also functionalized with the neuroactive peptide IKVAV were able to 
partially restore cognitive impairment upon PA-IKVAV injection into the hippocampus in 
Alzheimer’s disease mice model. This result was linked to markedly neurogenesis observed in 
treated mice. Additionally, Yang and co-workers observed a decrease in the levels of soluble 
aβ-40 aβ-42 and amyloid-β plaques probably derived from the IKVAV functionality (143). 
 
Table 2. Representative protein materials used for an integrated biological control of cell 
proliferation. 
 
Material  Presentation  Application  Reference 
Mussel adhesive 
proteins 
Scaffold coated Enhances cell adhesion, 
proliferation and 
osteogenic formation in 
vitro and in vivo 
(102)
  
Silk fibroin Electrospun matrices Enhances adhesion of 
different cell types in vitro 
(101)
  
Fibronectin Coating surfaces Enhances adhesion and 
retains regenerative 
capacity of human 
hematopoietic Stem Cells 
ex vivo 
(144)
  
Laminin E8 Coating surfaces Support efficient 
(145)
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fragment adhesion and expansion of 
dissociated human 
pluripotent stem cells 
Vitronectin Coating surfaces Promote adhesion and 
osteogenic diferenciation of 
human mesenchymal stem 
cells 
(146)
  
GFOGER Coating synthetic poly-
caprolactone (PCL) 
scaffolfs 
Increase and accelerate 
bone formation in critically-
sized segmental defects in 
rats 
(147)
  
Hialuronic acid (HA) HA-binding scaffold Improved cartilage tissue 
production in a rat knee 
osteochondral defect 
model  
(148)
  
Elastin-like 
polypeptides (ELP) 
with fibronectin cs5 
and a proteolytic 
domain 
Absorbed to glass surfaces Enhance epithelial cell 
attachment, proliferation, 
and retention of the 
differentiated 
phenotype in ocular surface 
tissue engineering 
(149)
  
Bone sialoprotein Surfaces coated with the 
oligomerized form 
Promote osteoblast 
adhesiveness 
(150)
  
Osteopontin Hydroxyapatite 
nanoparticles 
functionalized with 
osteopontin (OPN) in a 
matrix of poly-D,L-lactic-
acid (PDLLA) 
Increased the formation of 
new bone in the porosities 
of a canine implant 
(151)
 
TGF- Cyclodextrin(CD)- and 
Cucurbituril(CB)-based 
hydrogels 
Effective chondrogenic 
differentiation 
(115)
 
VEGF PEG-based hydrogels Stimulates cell migration 
and proliferation and 
maintain cell viability 
(116,117)
 
VEGF Embedded in gelatine-like 
gels 
Nerve grow stimulation in 
in vitro models 
(152)
 
NGF PLA-b-PEG-b-PLA microgel Material with potential to 
maintain NGF activity in the 
peripheral nervous system 
(153)
 
BFGF-2 In surface-coated 
amyloidal micro-particles 
 
Stimulation of cell 
proliferation in 2D and 3D 
scaffolds  
(132)
  
TGF-3 and BMP-2 Embedded in alginate 
hydogels 
Bone regeneration in in 
vivo models 
(112)
 
TGF-3 and BMP-2 Embedded in alginate 
hydogels 
Improves tissue deposition 
(113)
 
VEGF and BMP-2 Embedded in alginate 
hydogels 
Enhances migration and 
collagen deposition 
(113,114)
  
Supramolecular 
insulin assemblies 
(SIA) 
LbL films Long term control of 
glucose levels 
(125)
  
GnRH analogues Amyloid fibers Treatment of sex-steroid 
dependent 
pathophysiologies 
(126)
  
Retinoic Acid – Κ- 
Casein 
RA functionalizing amyloid 
K casein hydrogel 
Neuronal differentiation 
(136)
  
IGF-1 Functionalizing amyloid 
fibrils 
Improve cardiac myocyte 
survival and growth in 
(137)
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infarctation rat models 
Bacterial inclusion 
bodies 
Functionalizing 2D and 3D 
cell culture scaffolds 
Show promise as protein 
drug delivery platform 
(127)
  
IKVAV or RGD  Functionalizing PA fibers In vitro and in vivo neurite 
growth stimulation 
(142)
  
IKVAV  Functionalizing PA fibers Restores cognitive 
impairment in Alzheimer’s 
disease 
(143)
  
IKVAV Immobilized on different 
dextran-coated materials 
Promote substantial neuron 
cell adhesion and neurite 
outgrowth,  and minimal 
fibroblast and glial cell 
adhesion 
(154)
  
 
Future perspective 
The comprehension of how cells respond to their environment, regarding the set of complex 
mechanical, biomechanical and biological stimuli provide by the ECM, is gained by the analyses 
of individual effectors or effector categories and their impact on cell biology. Then, 2D and 3D 
scaffolds are under development to offer appropriate surface roughness at both nano and 
micro scales to stimulate cell attachment, proliferation and differentiation and to modulate 
cell positioning and fate in regenerative medicine. In parallel, protein materials with 
appropriate biological and mechanical properties (such as adhesiveness) might serve for 
coating complicated scaffolds to provide more cell-friendly supports. In an attempt to 
integrate the range of stimuli, soluble protein factors, usually available upon external supply, 
are being incorporated into new-generation scaffolds, which act as topographies and 
simultaneously as drug reservoirs for sustained release along the tissue formation process. The 
expected gain of a temporal control over the activity of such hybrid materials and the resulting 
factor supply will necessarily conduce to designing smarter, bio-inspired scaffolds for a more 
accurate and integrative mimicry of cellular environment and a tighter control of tissue 
formation in artificial but biomimetic settings.  
 
Executive summary 
Engineering scaffold topography Engineering surface topology by either top-down or bottom-
up approaches offers a convenient way to modulate cell functions critical for tissue 
engineering such as attachment, proliferation, positioning, migration and differentiation. 
Lithographic techniques are powerful instruments to topographically control cell behavior in 
modified scaffolds. 
As a surface engineering method, particle deposition remains, instead, less dependent on the 
surface material chemistry and offers a high versatility in the control of patterning.   
Diverse materials and biomaterials are suitable for the fabrication of biocompatible 2D and 3D 
scaffolds.  
Surface-engineered 3D scaffolds offer extremely interesting settings for the structural mimicry 
of the ECM. 
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Tailoring bio-functional protein materials 
A set of natural or modified proteins and peptides allow coating of unfriendly materials for 
efficient cell colonization, enabling the applicability in tissue engineering of xenobiotic 
materials that are appealing from the fabrication point of view.  
Developing functional drug-releasing biomaterials 
Hydrogels and other polymeric materials adapted as 3D scaffolds for tissue engineering can be 
loaded with soluble protein factors with impact in tissue formation, for sustained release 
during cell colonization. 
Hydrogels can be tuned and functionalized for very precise specific applications in tissue 
engineering such as nerve tissue regeneration and angiogenesis. 
Full-length proteins resulting from biofabrication and natural or synthetic peptides are being 
engineered to form bio-inspired matrices for fast and efficient cell colonization. 
Amyloidal materials are specifically suitable for the slow release of their bio-active building 
blocks, mimicking the performance of hormone secretory granules in the endocrine system 
and avoiding the external supply of soluble factors. 
The combination of both topography and biological effectors in these protein materials offer a 
refreshing approach to the generation of bio-inspired, bio-active substrates (bioscaffolds) for 
tightly controlled, self-contained tissue engineering platforms. 
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Figure 1. Tissue engineering requires both addressing substrate topography requirements at 
the cell sensing scale and providing appropriate biological stimuli for proper cell adhesion, 
positioning, migration, proliferation, differentiation and activity (top). This is intended to finely 
replicate ex vivo and in vivo features of the ECM in synthetic platforms, to finely regulate cell 
behavior in a targeted way (bottom). Plain engineering of surface topography through top-
down and bottom up approaches have generated numerous insights about how cells respond 
to mechanical stimuli. On the other hand, soluble factors (mainly proteins) are progressively 
incorporated to 3D scaffolds for their local release, while proteins themselves are exploited for 
their adhesive properties and architectonic potential in form of coating layers, fibers, 
hydrogels and amyloids. Although still far from clinical implementation, bioinspired, hybrid and 
homogeneous protein materials are showing themselves as promising alternatives to 
separated topographical and biological effectors for an integrative manipulation of cells in 
tissue engineering. 
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